Newstral
Article
bizjournals.com on 2020-02-03 16:44
Redwood City biotech boosts IPO targets, hopes to raise up to $184M
Related news
- Redwood City biotech boosts IPO targets, hopes to raise up to $184Mbizjournals.com
- Redwood City medical device maker Pulmonx boosts IPO targets by 69%bizjournals.com
- MKrystal Biotech boosts IPO share offeringmarketwatch.com
- Mountain View search company Elastic boosts IPO targets by 21%bizjournals.com
- Redwood City data analytics unicorn Sumo Logic files IPO plansbizjournals.com
- Redwood City medical device maker Pulmonx tops IPO targets, raises $190Mbizjournals.com
- Redwood City medical device maker Pulmonx sets targets for $123M IPObizjournals.com
- Here's how Redwood City biotech tripled its IPO price with a buyout in less than 4 monthsbizjournals.com
- Coupa Software boosts IPO targets 24%, hopes to raise up to $153Mbizjournals.com
- Redwood City ad-tech business PubMatic files to raise $75M in IPObizjournals.com
- Mountain View biotech boosts targets by 40% ahead of Wednesday IPObizjournals.com
- Bay Area biotech boosts IPO targets by 38%, hopes to raise up to $254Mbizjournals.com
- Genetic testing firm Invitae tops IPO targets, raises $102Mbizjournals.com
- Vancouver biotech firm Absci files for IPOoregonlive.com
- MMoleculin Biotech raises $9.2 million in IPOmarketwatch.com
- Biotech Startup NantHealth Targets IPO Market AgainInc.
- Cancer-fighting Peninsula biotech targets $100M IPObizjournals.com